Pages that link to "Q47334357"

The following pages link to Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study (Q47334357):

Displaying 39 items.

• Pharmacological treatments for fatigue associated with palliative care (Q24187756) (← links)
• Drug therapy for the management of cancer-related fatigue (Q24234267) (← links)
• Drug therapy for the management of cancer related fatigue (Q24242050) (← links)
• A randomized pilot study of atractylenolide I on gastric cancer cachexia patients (Q24654205) (← links)
• What has been learned from measuring health-related quality of life in clinical oncology. (Q30326186) (← links)
• Use of quality-of-life outcome assessments in current cancer clinical trials (Q33583284) (← links)
• The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer (Q33874156) (← links)
• High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. (Q33945113) (← links)
• Cancer cachexia. (Q33960626) (← links)
• Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial (Q33968290) (← links)
• A review of the drug treatment of cachexia associated with cancer (Q34066519) (← links)
• Update on anorexia and cachexia (Q34143728) (← links)
• Treatment of the cancer anorexia-cachexia syndrome: a critical reappraisal (Q34215052) (← links)
• Managing cancer-related anorexia/cachexia (Q34233269) (← links)
• Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia (Q34294263) (← links)
• Cachexia and asthenia in cancer patients (Q34571829) (← links)
• Placebo effects in oncology (Q35037527) (← links)
• Outcome research in palliative care: could it represent a new dimension of clinical research or clinical practice? (Q35973448) (← links)
• Fatigue in palliative care patients -- an EAPC approach (Q37063833) (← links)
• Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome (Q37103603) (← links)
• Overview of emerging pharmacotherapy in chronic heart failure (Q37552943) (← links)
• Targeted therapy in renal cancer (Q37905587) (← links)
• Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia. (Q37924325) (← links)
• Current pharmacotherapy options for cancer anorexia and cachexia (Q38052613) (← links)
• A systematic review of health-related quality of life instruments in patients with cancer cachexia (Q38116773) (← links)
• Promoting symptom control in palliative care (Q43071064) (← links)
• Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. (Q44969554) (← links)
• Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma (Q47169310) (← links)
• Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy (Q50248491) (← links)
• A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer (Q51670696) (← links)
• Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. (Q52714644) (← links)
• A clinical model for quality of life assessment in cancer patients receiving chemotherapy. (Q53528875) (← links)
• Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial. (Q53541420) (← links)
• Should cancer patients with incurable disease receive parenteral or enteral nutritional support? (Q53574842) (← links)
• Assessment and Treatment of the Anorexia of Aging: A Systematic Review (Q61796778) (← links)
• Cancer cachexia (Q73290028) (← links)
• Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group (Q73329373) (← links)
• The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy (Q73731761) (← links)
• Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer (Q74128415) (← links)